Obesity and resistance to cancer chemotherapy: interacting roles of inflammation and metabolic dysregulation.
about
Obesity and cancer: mechanistic insights from transdisciplinary studiesImpact of obesity on chemotherapy management and outcomes in women with gynecologic malignanciesThe impact of insulin on chemotherapeutic sensitivity to 5-fluorouracil in gastric cancer cell lines SGC7901, MKN45 and MKN28.Weight control interventions improve therapeutic efficacy of dacarbazine in melanoma by reversing obesity-induced drug resistanceOptimizing care for the obese patient in interventional radiologyInteractions between the colonic transcriptome, metabolome, and microbiome in mouse models of obesity-induced intestinal cancer.Identification of long non-coding RNA signature for paclitaxel-resistant patients with advanced ovarian cancer.Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer.Resveratrol inhibits obesity-associated adipose tissue dysfunction and tumor growth in a mouse model of postmenopausal claudin-low breast cancer.Implication of visceral obesity in patients with esophageal squamous cell carcinoma.Translating Mechanism-Based Strategies to Break the Obesity-Cancer Link: A Narrative Review.Clinical Impact of Abdominal Fat Distribution on Prognosis After Esophagectomy for Esophageal Squamous Cell Carcinoma.Elevated circulatory levels of leptin and resistin impair therapeutic efficacy of dacarbazine in melanoma under obese state.
P2860
Q26786829-AEED447B-3495-42AC-8169-A5443EFA0A98Q35748477-2B8D4EAF-0D14-4B81-BC23-9375D346DEADQ35828140-0D23B9F2-93D7-4E6C-ABCA-C8731DCC3707Q37480946-C04BC440-1CDE-4617-92DD-43FC54E852B8Q39084404-1E854F4D-729D-45FF-823C-69CC31908C13Q39673717-CC50F0C3-2B15-444E-8C91-17B07B68CC8FQ42085801-BD64462A-9795-434C-BBC3-45B4149EB8CDQ47288520-9F20D261-0B1D-4616-A6D6-798570D792FDQ47570409-AC44B0FF-B6E2-43E4-A4A9-C5CFCFCC25EDQ49352949-061325C6-B2AB-46AF-809E-E5CBD186C774Q50162842-2239B8C8-8758-498E-B719-8889B09A773EQ53244089-168B1F95-69C9-4DF1-8970-23212A72C20BQ55158049-365CEF69-0DB3-47D5-9E1F-72BFAA86E326
P2860
Obesity and resistance to cancer chemotherapy: interacting roles of inflammation and metabolic dysregulation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Obesity and resistance to canc ...... n and metabolic dysregulation.
@en
type
label
Obesity and resistance to canc ...... n and metabolic dysregulation.
@en
prefLabel
Obesity and resistance to canc ...... n and metabolic dysregulation.
@en
P2093
P2860
P356
P1476
Obesity and resistance to canc ...... n and metabolic dysregulation.
@en
P2093
L M Lashinger
S D Hursting
P2860
P304
P356
10.1038/CLPT.2014.136
P407
P577
2014-06-24T00:00:00Z